Literature DB >> 19491838

The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.

Su-Yeon Choi1, Donghee Kim, Hwa Jung Kim, Jin Hwa Kang, Su Jin Chung, Min Jung Park, Young Sun Kim, Chung Hyun Kim, Seung Ho Choi, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Sang-Heon Cho, Myung-Whun Sung, Byung-Hee Oh.   

Abstract

OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is known to be related to factors that predict the development of coronary heart disease (CHD), such as dyslipidemia, central obesity, and metabolic syndrome (MS). The aim of this study was to determine whether individuals with NAFLD have an elevated risk of CHD, as estimated using the Framingham risk score (FRS).
METHODS: A total of 21,130 individuals who underwent a voluntary general health examination were recruited. NAFLD was diagnosed among these individuals on the basis of typical sonographic findings and a level of alcohol consumption of <20 g/day. Of the 21,130 individuals, 3,780 were excluded because they had known causes of liver disease (1,690 were alcoholics, 975 had hepatitis B virus, 242 had hepatitis C virus, 91 had other hepatitis history, and 593 were taking medication known to produce fatty liver) or a history of heart disease (189).
RESULTS: NAFLD was diagnosed in 5,769 of the 17,350 individuals (33.3%). The 11,581 normal individuals constituted the control group. The 5,769 individuals with NAFLD were split into two groups on the basis of ultrasonographic findings, that is, into a mild NAFLD group (n=3,278) and a moderate-severe NAFLD group (n=2,491). Individuals with NAFLD had an elevated risk of CHD, as estimated using FRS. Multivariable regression analysis, adjusted for confounding factors, showed a strong association between a higher FRS and NAFLD.
CONCLUSIONS: Individuals with ultrasonographically detected NAFLD have an elevated 10-year risk of developing CHD as estimated using FRS. Furthermore, NAFLD was found to be independently related to the risk of developing CHD, regardless of classical risk factors and other components of MS.

Entities:  

Mesh:

Year:  2009        PMID: 19491838     DOI: 10.1038/ajg.2009.238

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  44 in total

Review 1.  Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Melanie D Beaton
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Authors:  Donghee Kim; Su-Yeon Choi; Eun Ha Park; Whal Lee; Jin Hwa Kang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sook Hyang Jeong; Dong Ho Lee; Hyo-suk Lee; Joseph Larson; Terry M Therneau; W Ray Kim
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

3.  Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Jie Xing; Xue Guan; Qian Zhang; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Obes Facts       Date:  2021-03-29       Impact factor: 3.942

4.  Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.

Authors:  Hyo Eun Park; Heesun Lee; Su-Yeon Choi; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim; Goh Eun Chung
Journal:  J Gastroenterol       Date:  2018-10-04       Impact factor: 7.527

Review 5.  The role of lifestyle changes in the management of chronic liver disease.

Authors:  Valerio Nobili; Christine Carter-Kent; Ariel E Feldstein
Journal:  BMC Med       Date:  2011-06-06       Impact factor: 8.775

6.  The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes.

Authors:  A Sidney Barritt; Evan S Dellon; Tomasz Kozlowski; David A Gerber; Paul H Hayashi
Journal:  J Clin Gastroenterol       Date:  2011-04       Impact factor: 3.062

7.  Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.

Authors:  Seung Mi Lee; Soo Heon Kwak; Ja Nam Koo; Ig Hwan Oh; Jeong Eun Kwon; Byoung Jae Kim; Sun Min Kim; Sang Youn Kim; Gyoung Min Kim; Sae Kyung Joo; Bo Kyung Koo; Sue Shin; Chanthalakeo Vixay; Errol R Norwitz; Chan-Wook Park; Jong Kwan Jun; Won Kim; Joong Shin Park
Journal:  Diabetologia       Date:  2018-11-23       Impact factor: 10.122

8.  Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans.

Authors:  Dae Hee Choi; Sung Joon Lee; Chang Don Kang; Myoung Ok Park; Dong Wook Choi; Tae Suk Kim; Wonho Lee; Byung Ryul Cho; Yong Hoon Kim; Bong-ki Lee; Dong Ryeol Ryu; Ji Won Lee
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

9.  Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD.

Authors:  Alejandro A Diaz; Tom P Young; Sila Kurugol; Erick Eckbo; Nina Muralidhar; Joshua K Chapman; Gregory L Kinney; James C Ross; Raul San Jose Estepar; Rola Harmouche; Jennifer L Black-Shinn; Matthew Budoff; Russell P Bowler; John Hokanson; George R Washko
Journal:  Chronic Obstr Pulm Dis       Date:  2015

10.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.